Gene · 53353
Papers2,235
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,235
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antitumor immunity and prognosis value elicited by FAT3 and LRP1B co-mutation in endometrial cancer. | Gynecol Oncol | 2024 | 38696842 | PubTator, text mining | PubMed |
| The immune response-related genomic alterations in patients with malignant melanoma. | Medicine (Baltimore) | 2024 | 38669390 | PubTator, text mining | PubMed |
| Somatic mutations that affect early genetic progression and immune microenvironment in gastric carcinoma. | Pathol Res Pract | 2024 | 38663178 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis. | J Pathol Clin Res | 2024 | 38661052 | PubTator, text mining | PubMed |
| Prevalence and Associations of Co-occurrence of NFE2L2 Mutations and Chromosome 3q26 Amplification in Lung Cancer. | Glob Med Genet | 2024 | 38628662 | PubTator, text mining | PubMed |
| LDL Receptor-Related Protein 1B Polymorphisms Associated with Increased Risk of Lymph Node Metastasis in Oral Cancer Group with Diabetes Mellitus. | Int J Mol Sci | 2024 | 38612772 | PubTator, text mining | PubMed |
| Identification of nomogram associated with durable clinical benefit gene for advanced non-small cell lung cancer with sensitivity to responsive to immunotherapy. | Heliyon | 2024 | 38560208 | PubTator, text mining | PubMed |
| Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real-world clinical tumor sequencing study. | J Pathol Clin Res | 2024 | 38504382 | PubTator, text mining | PubMed |
| Total Neoadjuvant Therapy With PD-1 Blockade for High-Risk Proficient Mismatch Repair Rectal Cancer. | JAMA Surg | 2024 | 38381429 | PubTator, text mining | PubMed |
| An Investigation of the Immune Microenvironment and Genome during Lung Adenocarcinoma Development. | J Cancer | 2024 | 38370388 | PubTator, text mining | PubMed |
| Next-generation sequencing reveals remarkable genetic stability in primary and corresponding recurrent intestinal-type sinonasal adenocarcinoma. | Head Neck | 2024 | 38362701 | PubTator, text mining | PubMed |
| Identification and validation of a 4-extracellular matrix gene signature associated with prognosis and immune infiltration in lung adenocarcinoma. | Heliyon | 2024 | 38293522 | PubTator, text mining | PubMed |
| Predicting colorectal cancer prognosis based on long noncoding RNAs of disulfidptosis genes. | World J Clin Oncol | 2024 | 38292658 | PubTator, text mining | PubMed |
| Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity. | Cancer Res Commun | 2024 | 38282550 | PubTator, text mining | PubMed |
| Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma. | BMC Med | 2024 | 38281914 | PubTator, text mining | PubMed |
| Mapping the landscape of HPV integration and characterising virus and host genome interactions in HPV-positive oropharyngeal squamous cell carcinoma. | Clin Transl Med | 2024 | 38279874 | PubTator, text mining | PubMed |
| Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial. | Clin Cancer Res | 2024 | 38277235 | PubTator, text mining | PubMed |
| Epigenetic Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus. | Int J Mol Sci | 2024 | 38256093 | PubTator, text mining | PubMed |
| The Role of Human Papilloma Virus (HPV) in Primary Lung Cancer Development: State of the Art and Future Perspectives. | Life (Basel) | 2024 | 38255725 | PubTator, text mining | PubMed |
| Li-Fraumeni syndrome presenting with de novo TP53 mutation, severe phenotype and advanced paternal age: a case report. | Hered Cancer Clin Pract | 2024 | 38238849 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53353/papers?page=8